Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
Background: Anti-SARS-CoV-2 monoclonal antibodies (mAbs) have played a key role as an antiviral against SARS-CoV-2, but there is a potential for resistance to develop. The interplay between host antibody responses and the development of monoclonal antibody (mAb) resistance is a critical area of inve...
Saved in:
Main Authors: | Marc-Kendy Paul (Author), Manish Choudhary (Author), Amy Heaps (Author), Rinki Deo (Author), Daniela Moisi (Author), Kelley Gordon (Author), John Mellors (Author), Carlee Moser (Author), Paul Klekotka (Author), Alan Landay (Author), Judith Currier (Author), Joseph Eron (Author), Kara Chew (Author), Davey Smith (Author), Scott Sieg (Author), Urvi Parikh (Author), Jonathan Li (Author) |
---|---|
Format: | Book |
Published: |
Case Western Reserve University,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment
by: Urvi Parikh, et al.
Published: (2024) -
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
by: Katya Corado, et al.
Published: (2024) -
Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
by: Urvi S. Zankharia, et al.
Published: (2020) -
Production and Characterization of a Monoclonal Antibody Neutralizing Poliovirus Type 2
by: Morteza Kamalzadeh, et al.
Published: (2019) -
Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil.
by: Alex Pauvolid-Corrêa, et al.
Published: (2017)